IMPACT OF HEALTH POLICY CHANGES ON UNIT SALES OF 5 TOP SELLING ATC1 PHRAMACEUTICAL GROUPS IN TURKEY
Author(s)
Saylan M1, Safak Yilmaz E2, Yenilmez FB3, Kockaya G1, Tatar M3, Hilal Vural E2, Vural IM2, Akbulat A2, Gursoz H2, Artiran G2, Kerman S2
1Health Economics and Policy Association, Ankra, Turkey, 2Turkish Medicines and Medical Devices Agency, Ankara, Turkey, 3Hacettepe University, Ankara, Turkey
OBJECTIVES: Turkish Ministry of Health (MoH) initiated Health Transformation Program (HTP) in 2002. HTP impacted all clinical and economic outcomes of health including pharmaceutical sales by improving access to health services. The objective of this study is to understand the differences in the impact of selected 5 policies on 5 top selling ATC1 groups in terms of unit sales(US) in the respective periods. METHODS:
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PHP37
Topic
Health Policy & Regulatory
Topic Subcategory
Pricing Policy & Schemes
Disease
Multiple Diseases